PsiQuantum has formed a strategic partnership with the National Cancer Center Japan to accelerate the development of quantum computing applications in healthcare, particularly in oncology. The collaboration aims to harness the power of fault-tolerant quantum algorithms to tackle complex challenges in drug discovery, resource allocation, and patient outcomes. By leveraging quantum computing's ability to simulate molecular systems, researchers can gain unprecedented insights into the behavior of molecules, leading to potential breakthroughs in cancer treatment. This partnership has the potential to revolutionize the field of oncology by enabling the discovery of new drugs and improving patient care1. The integration of quantum computing in healthcare can lead to significant advancements in the field, and this partnership is a crucial step towards realizing that goal. This matters to practitioners because it has the potential to significantly improve patient outcomes and treatment options, making it a crucial development in the field of quantum healthcare.